Cambridge, MA, United States of America

Javad Golji

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Javad Golji. Retrieved from https://idiyas.com/inventor/javad-golji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Javad Golji: Innovator in Cancer Treatment

Introduction

Javad Golji is a prominent inventor based in Cambridge, MA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on developing personalized therapies that aim to improve patient outcomes in oncology.

Latest Patents

Golji holds a patent for "Compositions and methods to treat cancer." This patent provides novel personalized therapies, kits, transmittable forms of information, and methods for treating patients with cancer. The therapies are designed for cancers that can be treated with inhibitors, including those targeting specific disclosed pathways. The patent also includes methods for screening candidate inhibitors and associated treatment methods.

Career Highlights

Javad Golji has established himself as a key figure in the pharmaceutical industry, particularly through his work at Novartis AG. His research and innovations have the potential to transform cancer treatment and provide new hope for patients.

Collaborations

Golji has collaborated with notable colleagues, including Eric Billy and Antoine De Weck, to advance his research and develop effective cancer therapies.

Conclusion

Javad Golji's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his commitment to improving patient care. His work continues to pave the way for advancements in personalized medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…